New Age Alpha Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.9M Sell
8,257
-171
-2% -$175K 0.42% 44
2026
Q1
$7.75M Sell
8,428
-411
-5% -$417K 0.36% 58
2025
Q4
$9.5M Sell
8,839
-3,711
-30% -$3.55M 0.41% 43
2025
Q3
$9.58M Buy
12,550
+1,658
+15% +$1.23M 0.4% 44
2025
Q2
$8.49M Sell
10,892
-13
-0.1% -$10.1K 0.37% 55
2025
Q1
$9.01M Sell
10,905
-1,875
-15% -$1.56M 0.4% 53
2024
Q4
$9.87M Buy
+12,780
New +$10.6M 0.4% 53

Other funds holding LLY

New Age Alpha Advisors's LLY Position: Q2 2026 in Review

New Age Alpha Advisors reduced its Eli Lilly (LLY) stake by 2% in Q2 2026, selling an estimated $175K and leaving 8,257 shares worth $9.9M. The position accounts for 0.42% of the portfolio, ranked #44.

New Age Alpha Advisors first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • New Age Alpha Advisors held 8,257 shares of Eli Lilly worth $9.9M as of Q2 2026.
  • New Age Alpha Advisors sold 171 Eli Lilly shares in Q2 2026, an estimated $175K.
  • Eli Lilly made up 0.42% of New Age Alpha Advisors's portfolio in Q2 2026, its #44 holding.
  • New Age Alpha Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on New Age Alpha Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.